Industries
Top countries
Publication dates
Publishers
All regions
data types
1-20 of about 700 reports for Hormone
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription. This report ...
Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI
Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI
Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various ...
This report provides data on the therapeutic development for Neuroendocrine Tumors, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
China's demand for osteoporosis treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic ...
There are today 249 companies plus partners developing 290 drugs targeting pancreatic cancer in development. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the ...
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...
China's demand for blood treatment disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic ...
China's demand for anti-tumor drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, ...
Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...
Summary Bioenvision, Inc. (Bioenvision) is a pharmaceutical company, engaged in acquiring, developing and marketing compounds and technologies used in the treatment of cancer. Bioenvision's primary products ...
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI
Yearly, From 2004 To 2008
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
» Download Public Reports
About 2 400 reports for Hormone
» Read our Company Profiles
6 Companies for HormoneReportlinker.com © Copyright 2013. All rights reserved.